FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE
Labeling changes approved for FOSUN PHARMA. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025
Labeling changes approved for FOSUN PHARMA. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025
There are no comments here yet...